Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Distract your brain, heal your shoulder? new study tests Attention-Shift exercise

NCT ID NCT07546084

Symptom relief Sponsor: Istanbul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new exercise approach for people with long-term shoulder pain caused by rotator cuff problems. Instead of just doing standard shoulder exercises, participants will also perform movements that shift their focus away from the shoulder. The goal is to see if this attention-shift method reduces pain and improves shoulder function better than standard exercises alone. About 46 adults with at least 3 months of shoulder pain will take part in supervised sessions twice a week for 6 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 46 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having symptoms persisting for at least 3 months * Experiencing pain intensity of at least 3 on the Numeric Pain Rating Scale (NPRS) during activity * Presence of a painful arc during shoulder flexion or abduction * Positive Neer test or Hawkins-Kennedy test * Pain provoked by resisted external rotation/abduction of the humerus, or a positive Jobe (Empty Can) test * Having a clinical diagnosis of subacromial pain syndrome, rotator cuff tendinopathy, subacromial bursitis, or symptomatic partial/full-thickness rotator cuff tear * Being able to understand and complete questionnaires in Turkish Exclusion Criteria: * Presence of adhesive capsulitis (≥30% limitation in passive range of motion) * Advanced osteoarthritis of the shoulder * History of fracture or dislocation affecting the shoulder region * Advanced acromioclavicular joint pathology * Massive rotator cuff tear (positive lag signs) * Previous shoulder surgery * Presence of neurological disorders * Diagnosis of rheumatoid arthritis * History of cancer * Symptomatic cervical spine pathology * Corticosteroid injection to the shoulder within the past 6 weeks * Cognitive impairments that may interfere with the ability to perform clinical tasks or execute attention shift-based exercises

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff related shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bursitis disease of the tendon rotator cuff syndrome shoulder impingement syndrome Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff related shoulder pain Rotator cuff tears of the shoulder Shoulder bursitis Shoulder tendinopathy Subacromial pain syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul University-Cerrahpasa

    RECRUITING

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.